Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Head-and-Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchEnded earlyNCT01587820
What this trial is testing

Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer

Who this might be right for
Head and Neck Cancer
Southern Illinois University 1
Early research (Phase 1)Looking for participantsNCT07232524
What this trial is testing

BL-M24D1 in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 16
Not applicableNot Yet RecruitingNCT07780968
What this trial is testing

Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA

Who this might be right for
Esophageal CancerGastroEsophageal CancerGastroesophageal-junction Cancer+2 more
Jazz Pharmaceuticals 300
Large-scale testing (Phase 3)Study completedNCT00003888
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 359
Not applicableWithdrawnNCT06420908
What this trial is testing

Adebrelimab Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital
Early research (Phase 1)Looking for participantsNCT07229313
What this trial is testing

KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advance Solid Tumors
Kivu Bioscience Inc. 76
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Testing effectiveness (Phase 2)Looking for participantsNCT07814287
What this trial is testing

Becotatug Vedotin Plus Pucotenlimab and Platinum Chemotherapy in Locally Advanced Epidermal Growth Factor Receptor (EGFR)-Positive Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma, HNSCC
Xuekui Liu 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05993858
What this trial is testing

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaNeoadjuvant Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 33
Early research (Phase 1)Looking for participantsNCT07455032
What this trial is testing

Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Fox Chase Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT05213884
What this trial is testing

The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Chongqing University Cancer Hospital 39
Testing effectiveness (Phase 2)Study completedNCT02605967
What this trial is testing

Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Novartis Pharmaceuticals 122
Not applicableUnknownNCT02352792
What this trial is testing

Hypoxia-based Dose Escalation With Radiochemotherapy in Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University Hospital Tuebingen 90
Testing effectiveness (Phase 2)Temporarily pausedNCT04084158
What this trial is testing

Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00072033
What this trial is testing

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 66
Testing effectiveness (Phase 2)UnknownNCT04440917
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 32
Not applicableStudy completedNCT05303740
What this trial is testing

Anlotinib Retrospective Study for Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
Feng Wang 300
Early research (Phase 1)Looking for participantsNCT06500052
What this trial is testing

BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+2 more
Sichuan Baili Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)UnknownNCT04514835
What this trial is testing

A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 44
Testing effectiveness (Phase 2)UnknownNCT04644250
What this trial is testing

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Wei Ren 32
Next Page